Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

PHASE4CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Pulmonary InfectionsPseudomonas Aeruginosa in Cystic Fibrosis
Interventions
DRUG

TBM100

Tobramycin inhalation powder was assigned as four capsules at 28mg dosage strength. It was inhaled b.i.d in the morning and in the evening via the T-326 Inhaler.

Trial Locations (49)

1121

Novartis Investigative Site, Budapest

2305

Novartis Investigative Site, New Lambton Heights

3052

Novartis Investigative Site, Parkville

3168

Novartis Investigative Site, Clayton

16147

Novartis Investigative Site, Genova

29425

Novartis Investigative Site, Charleston

29684

Novartis Investigative Site, Roscoff

30322

Novartis Investigative Site, Atlanta

32207

Novartis Investigative Site, Jacksonville

34059

Novartis Investigative Site, Montpellier

37126

Novartis Investigative Site, Verona

44106

Novartis Investigative Site, Cleveland

44308

Novartis Investigative Site, Akron

45147

Novartis Investigative Site, Essen

46026

Novartis Investigative Site, Valencia

50139

Novartis Investigative Site, Florence

51092

Novartis Investigative Site, Reims

53226

Novartis Investigative Site, Milwaukee

60590

Novartis Investigative Site, Frankfurt

63110

Novartis Investigative Site, St Louis

64460

Novartis Investigative Site, Monterrey

68198

Novartis Investigative Site, Omaha

72205

Novartis Investigative Site, Little Rock

73104

Novartis Investigative Site, Oklahoma City

73112

Novartis Investigative Site, Oklahoma City

75006

Novartis Investigative Site, Paris

75230

Novartis Investigative Site, Dallas

76104

Novartis Investigative Site, Fort Worth

77030

Novartis Investigative Site, Houston

78212

Novartis Investigative Site, San Antonio

80131

Novartis Investigative Site, Napoli

80206

Novartis Investigative Site, Denver

83406

Novartis Investigative Site, Giens

89107

Novartis Investigative Site, Las Vegas

90100

Novartis Investigative Site, Palermo

98125

Novartis Investigative Site, Messina

98405

Novartis Investigative Site, Tacoma

07962

Novartis Investigative Site, Morristown

53792-1615

Novartis Investigative Site, Madison

C1425DTG

Novartis Investigative Site, Caba

C1425EFD

Novartis Investigative Site, Capital Federal

X5014AKN

Novartis Investigative Site, Córdoba

E3100FKA

Novartis Investigative Site, Paraná

T2N 4n1

Novartis Investigative Site, Calgary

T6G 2B7

Novartis Investigative Site, Edmonton

H3T1C5

Novartis Investigative Site, Montreal

00161

Novartis Investigative Site, Roma

06720

Novartis Investigative Site, Mexico City

Unknown

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY